Yield10 Bioscience, Inc.

OTCPK:YTEN.Q Stock Report

Market Cap: US$249.4k

Yield10 Bioscience Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Yield10 Bioscience.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth27.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Yield10 Bioscience GAAP EPS of $0.70 beats by $1.39, revenue of $0.1M misses by $0.06M

Aug 10

Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Nov 12
Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Invest In Growth?

Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Jul 19
Yield10 Bioscience (NASDAQ:YTEN) Is In A Good Position To Deliver On Growth Plans

Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

May 18
Yield10 Bioscience, Inc.'s (NASDAQ:YTEN) CEO Will Probably Find It Hard To See A Huge Raise This Year

Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Apr 14
Here's Why We're Watching Yield10 Bioscience's (NASDAQ:YTEN) Cash Burn Situation

Yield10 Bio secures $12.7M capital raise

Feb 01

Yield10 Bioscience under pressure on launching stock offering

Jan 29

When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

Jan 22
When Will Yield10 Bioscience, Inc. (NASDAQ:YTEN) Become Profitable?

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Yield10 Bioscience has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

OTCPK:YTEN.Q - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20241-13-6-6N/A
3/31/20240-13-8-8N/A
12/31/20230-14-10-10N/A
9/30/20230-14-11-11N/A
6/30/20230-14-12-12N/A
3/31/20230-14-11-11N/A
12/31/20220-14-12-11N/A
9/30/20221-13-11-11N/A
6/30/20220-12-10-10N/A
3/31/20221-12-10-10N/A
12/31/20211-11-9-9N/A
9/30/20211-11-9-9N/A
6/30/20211-10-9-9N/A
3/31/20211-9-9-9N/A
12/31/20201-10-9-9N/A
9/30/20201-14-10-10N/A
6/30/20201-14-9-9N/A
3/31/20201-14-9-9N/A
12/31/20191-13-9-9N/A
9/30/20191-8-7-7N/A
6/30/20191-9-8-8N/A
3/31/20191-9-8-8N/A
12/31/20181-9-9-9N/A
9/30/20181-11-9-9N/A
6/30/20181-11-9-9N/A
3/31/20181-11N/A-9N/A
12/31/20171-11N/A-8N/A
9/30/20171-8N/A-9N/A
6/30/20171-8N/A-11N/A
3/31/20171-8N/A-10N/A
12/31/20161-9N/A-14N/A
9/30/20161-11N/A-17N/A
6/30/20160-7N/A-17N/A
3/31/20161-10N/A-22N/A
12/31/20151-12N/A-22N/A
9/30/20152-15N/A-22N/A
6/30/20153-24N/A-23N/A
3/31/20153-25N/A-22N/A
12/31/20143-27N/A-25N/A
9/30/20142-29N/A-25N/A
6/30/20141-28N/A-26N/A
3/31/20142-29N/A-27N/A
12/31/20134-29N/A-27N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if YTEN.Q's forecast earnings growth is above the savings rate (2.6%).

Earnings vs Market: Insufficient data to determine if YTEN.Q's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if YTEN.Q's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if YTEN.Q's revenue is forecast to grow faster than the US market.

High Growth Revenue: Insufficient data to determine if YTEN.Q's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if YTEN.Q's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 16:26
End of Day Share Price 2024/12/27 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yield10 Bioscience, Inc. is covered by 16 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Han JangAegis Capital Corporation
Jinming LiuArdour Capital Investments, LLC
Benjamin KlieveB. Riley Wealth